In modern healthcare, in vitro diagnostics go far beyond simply telling a doctor whether a patient has a certain disease or not. Today, they are an integral part of decision-making along the entire continuum of a patient’s health or disease, enabling physicians to make full use of IVDs along the healthcare value chain.
IVDs have long been considered the “silent champion” of healthcare, influencing over 60% of clinical decision-making, while accounting for only about 2% of total healthcare spending.
Diagnostics allow laboratories to be the reliable partners that healthcare professionals need. It empowers doctors to make the right decisions for their patients at the right time; it allows people to have improved control over their health and wellbeing, and it gives payors and policymakers the confidence that they are investing in the right solutions for patients and the future of healthcare.
Modern diagnostics reduce costs by diminishing subsequent health problems, reducing hospitalisation and avoiding unnecessary treatment. The future of sustainable healthcare depends on diagnostics.
Performed on blood, tissue or other patient samples, in vitro diagnostics (IVDs) are a critical source of objective information for improved disease management and patient care.